Table 4. Postoperative outcome. Data are expressed in numbers or mean±SD.
| HRnormal (n=168) | HRreduced (n=31) | P value | |
|---|---|---|---|
| Highest CK-MB | 13.4±17.1 | 11.2±8.7 | 0.511 |
| Highest Tn-T | 0.47±2.29 | 0.63±1.47 | 0.715 |
| Postoperative MI | 22 (13.1%) | 2 (6.5%) | 0.382 |
| Stroke | 2 (1.2%) | 0 | 0.712 |
| Renal failure | 14 (10.1%) | 2 (6.5%) | 0.531 |
| Reoperation | 2 (1.2%) | 0 | 0.712 |
| Prolonged ventilation | 1 (0.6%) | 1 (3.2%) | 0.288 |
| A-fib development | 40 (23.8%) | 7 (22.6%) | 0.544 |
| Six months follow up | |||
| cardiac morbidities | 1 (0.6%) | 0 | 1.000 |
| restenosis | 16/105 (15.2%) | 0/16 (0%) | 0.126 |
HRnormal, normal heparin responsiveness; HRreduced, reduced heparin responsiveness; CK-MB, creatine kinase-MB; Tn-T, troponin-T; MI, myocardial infarction; A-fib, atrial fibrillation; restenosis, confirmed by computed tomographic angiography.